• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经肽Y和肽YY抑制大鼠纹状体中的腺苷酸环化酶活性。

Neuropeptide Y and peptide YY inhibit adenylate cyclase activity in the rat striatum.

作者信息

Westlind-Danielsson A, Andell S, Abens J, Bartfai T

机构信息

Department of Biochemistry, Arrhenius Laboratory, Stockholm, Sweden.

出版信息

Acta Physiol Scand. 1988 Mar;132(3):425-30. doi: 10.1111/j.1748-1716.1988.tb08347.x.

DOI:10.1111/j.1748-1716.1988.tb08347.x
PMID:2852438
Abstract

The equilibrium binding of [3H]propionyl neuropeptide Y ([ 3H]pNPY) to receptors in a crude synaptic membrane preparation from the rat striatum was influenced by GTP, which caused an apparent loss of high-affinity binding sites for [3H]pNPY. In the presence of GTP (10(-5) M), NPY and peptide YY (PYY) inhibited basal and forskolin-stimulated adenylate cyclase activity in a concentration-dependent manner in a cell-free preparation from rat striatum. The IC50 values for NPY and PYY were 1 X 10(-8) M and 1.4 x 10(-8) M respectively. The inhibitory action of NPY (10(-6) M) or of PYY (10(-6) M) was additive to that of acetylcholine (10(-4) M). The two peptides together also showed additivity (P less than 0.05) in inhibiting adenylate cyclase.

摘要

[3H]丙酰神经肽Y([3H]pNPY)与大鼠纹状体粗制突触膜制剂中受体的平衡结合受到GTP的影响,GTP导致[3H]pNPY的高亲和力结合位点明显丧失。在GTP(10^(-5) M)存在的情况下,神经肽Y(NPY)和肽YY(PYY)在大鼠纹状体无细胞制剂中以浓度依赖的方式抑制基础和福斯高林刺激的腺苷酸环化酶活性。NPY和PYY的IC50值分别为1×10^(-8) M和1.4×10^(-8) M。NPY(10^(-6) M)或PYY(10^(-6) M)的抑制作用与乙酰胆碱(10^(-4) M)的抑制作用具有相加性。这两种肽共同作用时在抑制腺苷酸环化酶方面也表现出相加性(P<0.05)。

相似文献

1
Neuropeptide Y and peptide YY inhibit adenylate cyclase activity in the rat striatum.神经肽Y和肽YY抑制大鼠纹状体中的腺苷酸环化酶活性。
Acta Physiol Scand. 1988 Mar;132(3):425-30. doi: 10.1111/j.1748-1716.1988.tb08347.x.
2
Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.肽YY和神经肽Y抑制血管活性肠肽刺激的大鼠小肠中3',5'-环磷酸腺苷的生成:肽与肽YY优先受体相互作用的结构要求
Endocrinology. 1989 Feb;124(2):692-700. doi: 10.1210/endo-124-2-692.
3
Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process.神经肽Y通过一种对百日咳毒素敏感的过程抑制牛肾上腺嗜铬细胞中福斯高林刺激的腺苷酸环化酶。
J Pharmacol Exp Ther. 1992 Dec;263(3):1479-86.
4
Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.脑内神经肽Y结合位点与输精管神经肽Y受体的结构比较需求
Mol Pharmacol. 1990 Oct;38(4):494-502.
5
Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists.大鼠纹状体突触膜的腺苷酸环化酶活性。毒蕈碱受体激动剂的抑制作用。
Mol Pharmacol. 1983 Mar;23(2):393-8.
6
125I-neuropeptide Y and 125I-peptide YY bind to multiple receptor sites in rat brain.125I-神经肽Y和125I-肽YY与大鼠脑中的多个受体位点结合。
Mol Pharmacol. 1988 Dec;34(6):779-92.
7
Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase activity in rat hippocampus.神经肽Y抑制大鼠海马中福斯高林刺激的腺苷酸环化酶活性。
Eur J Pharmacol. 1987 Apr 29;136(3):425-8. doi: 10.1016/0014-2999(87)90318-9.
8
Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.介导大鼠纹状体腺苷酸环化酶活性抑制的多巴胺受体的特性分析。
Mol Pharmacol. 1985 Aug;28(2):138-45.
9
Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.神经肽Y和肽YY通过一种对百日咳毒素敏感的G蛋白抑制人和犬脂肪细胞中的脂肪分解。
J Clin Invest. 1990 Jan;85(1):291-5. doi: 10.1172/JCI114425.
10
Effect of cholera toxin on the activation of adenylate cyclase by calmodulin in bovine striatum.霍乱毒素对牛纹状体中钙调蛋白激活腺苷酸环化酶的影响。
Mol Pharmacol. 1986 Nov;30(5):469-75.

引用本文的文献

1
Serotonin release in the rat brain cortex is inhibited by neuropeptide Y but not affected by ACTH1-24, angiotensin II, bradykinin and delta-sleep-inducing peptide.
Naunyn Schmiedebergs Arch Pharmacol. 1991 Feb;343(2):117-22. doi: 10.1007/BF00168597.